News & Events

In this section

Battelle Places Order with Instem for Provantis Preclinical and submit-SEND Software Solutions

Instem Solutions to Automate Full Range of R&D Processes

CONSHOHOCKEN, PA - (BUSINESS WIRE) – July 19, 2011 - -Instem, a leading provider of early development software applications, announced today that Battelle has purchased its Provantis® and submit™ preclinical software solutions to automate processes within their GLP compliant preclinical facilities.

Battelle is the world’s largest independent research and development organization. Battelle’s health and life science capabilities support development, delivery, testing, and evaluation of innovative solutions for the biotech, pharmaceutical, and agrochemical industries and government agencies.

Provantis is a modern, fully integrated software system for single users and global organizations engaged in
preclinical evaluation studies. Orchestrating every facet of preclinical drug safety assessment, Provantis streamlines processes and workflows with straightforward, intuitive functionality for simple or complex studies within a GLP or non-GLP environment, on-site or over the Web.

Part of the Centrus™ solution suite, Instem’s submit™ software supports the Standard for Exchange of Nonclinical Data (SEND) initiative. Submit is the only fully integrated solution in production today for companies using SEND for the exchange, review and submission of research data. Converting data from any source system into SEND files, submit allows sponsors, CRO’s and regulators to share, visualize and analyze study data more efficiently.

“Knowing the active role Battelle plays in conducting studies for a variety of clients, we are truly honored to welcome them as a new client,” said, John Anderson-Carter, VP North American Sales at Instem.

About Battelle

As the world’s largest, independent research and development organization, Battelle provides innovative solutions to the world’s most pressing needs through its four global businesses:  Laboratory Management; National Security; Health and Life Sciences; and Energy, Environment and Material Sciences. It advances scientific discovery and application by conducting $6.5 billion in global R&D annually through contract research, laboratory management and technology commercialization.  Headquartered in Columbus, Ohio, Battelle oversees 22,000 employees in more than 130 locations worldwide, including seven national laboratories which Battelle manages or co-manages for the U.S. Department of Energy and the U.S. Department of Homeland Security and a nuclear energy lab in the United Kingdom.

Battelle also is one of the nation’s leading charitable trusts focusing on societal and economic impact and actively supporting and promoting science, technology, engineering and mathematics (STEM) education.

Learn more at

About Instem

Instem is a leading supplier of IT applications to the early development healthcare market, delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.

Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.

Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.

Meeting clients at the intersection of investment & return™.

Press Contacts:

Gary Mitchell (US HQ)
Tel: 610-941-0990

Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600